| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |